Vera Therapeutics, Inc. (VERA)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20260 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Vera Therapeutics, Inc.’s names, not what it holds today.
3 published
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jul 13, 2023 | 2023/0220051 | DOSING OF POLYOMAVIRUS NEUTRALIZING ANTIBODIES | Pharmaceuticals | VERA THERAPEUTICS, INC. |
| Jul 8, 2021 | 2021/0206809 | PEPTIDE NUCLEIC ACID (PNA) MONOMERS WITH AN ORTHOGONALLY PROTECTED ESTER MOIETY | Organic fine chemistry | VERA THERAPEUTICS, INC. |
| Jun 10, 2021 | 2021/0171437 | PEPTIDE NUCLEIC ACID (PNA) MONOMERS WITH AN ORTHOGONALLY PROTECTED ESTER MOIETY AND NOVEL INTERMEDIATES AND METHODS RELATED THERETO | Organic fine chemistry | VERA THERAPEUTICS, INC. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.